Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News  >  Companies  >  All News

News : Companies

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

UTI Mutual Fund : UTI Dividend Yield Fund declares tax free dividend of 5%

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/14/2013 | 03:18pm CEST

PRESS RELEASE

UTI Dividend Yield Fund declares tax-free dividend of 5%
UTI Dividend Yield Fund declares tax-free dividend of 5% (Re.0.50 per unit on face value of Rs.10) under dividend option-existing plan. Pursuant to the payment of dividend, the NAV of the dividend option-existing plan of the scheme would fall to the extent of payout.
The record date for the dividend is June 19, 2013.
All unit holders registered under the dividend option-existing plan of UTI Dividend Yield Fund as on the record date will be eligible for this dividend. Also investors who join the dividend option-existing plan of the scheme on or before the cut off time of the record date will be eligible for the dividend.
The NAV of UTI Dividend Yield Fund on June 13, 2013 under dividend option-existing plan was Rs.12.9103.
UTI-Dividend Yield Fund is an open-ended equity oriented scheme. The investment objective of the scheme is to provide medium to long-term capital gains and / or dividend distribution by investing predominantly in equity and equity related instruments, which offer high dividend yield. Dividend Yield may be considered as high if it is greater than the dividend yield of the Nifty last released/ published by NSE.
Ms Swati Kulkarni is the fund manager of the scheme.
About UTI Mutual Fund
UTI Mutual Fund is a SEBI registered mutual fund whose Sponsors are State Bank of
India, Punjab National Bank, Bank of Baroda and Life Insurance Corporation of India.
UTI Mutual Fund is one of the largest mutual funds in India with investor accounts of
9.73 million under its 91 domestic schemes / plans as on May 31, 2013.

Sponsors: State Bank of India, Punjab National Bank, Bank of Baroda, Life Insurance Corporation of India

Corporate Office: UTI Tower, 'Gn' Block, Bandra-Kurla Complex, Bandra (East), Mumbai 400 051. Tel: 6678 6666

Website:www.utimf.com

PRESS RELEASE

Mumbai
June 14, 2013

Registered Office: UTI Tower, 'Gn' Block, Bandra - Kurla Complex, Bandra (E), Mumbai
- 400 051. Phone : 022-66786666. For more information please contact the nearest UTI Financial Centre or your AMFI/NISM certified UTI Mutual Fund independent Financial Advisor (IFA) for a copy of Statement of Additional Information, Scheme Information Document and Key Information Memorandum cum Application Form. Mutual Fund Investments are subject to market risks, read all scheme related
documents carefully

Sponsors: State Bank of India, Punjab National Bank, Bank of Baroda, Life Insurance Corporation of India

Corporate Office: UTI Tower, 'Gn' Block, Bandra-Kurla Complex, Bandra (East), Mumbai 400 051. Tel: 6678 6666

Website:www.utimf.com

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
10:50a INVINCIBLE INVESTMENT : Notice concerning Acquisition of Asset (preferred equity interest)
10:50a INVINCIBLE INVESTMENT : Notice concerning Issuance of New Investment Units and Secondary Distribution of Investment Units
10:50a INVINCIBLE INVESTMENT : Notice concerning Acquisition of Assets and Entering into Leasing Contract
10:50a INVINCIBLE INVESTMENT : Notice concerning Debt Financing
10:50a INVINCIBLE INVESTMENT : Notice concerning Revision of Forecast of Financial Results and Distribution for the 29th Fiscal Period Ending December 2017
10:50a INVINCIBLE INVESTMENT : Notice Concerning Amendment to Memorandum of Understanding on Preferential Negotiation Rights
10:50a INVINCIBLE INVESTMENT : Notice concerning Introduction of Unitholder Benefit Program
10:50a INVINCIBLE INVESTMENT : Performance Update for August 2017
10:50a DIASORIN : earned CE-mark extending sample claims for DiaSorin Molecular's Simplexa HSV 1 & 2 kit
10:50a DRIVER : Trading Update and Notice of Preliminary Results 21/09/17
Latest news "Companies"
Advertisement